نتایج جستجو برای: tumour targeting

تعداد نتایج: 205504  

2017
Daniela Augsburger Peter J. Nelson Thomas Kalinski Andrej Udelnow Thomas Knösel Monika Hofstetter Ji Wei Qin Yan Wang Arvid Sen Gupta Susanne Bonifatius Minglun Li Christiane J. Bruns Yue Zhao

Adult-type fibrosarcoma is a rare and highly aggressive subtype of soft tissue sarcomas. Due to the existence of other spindle-cell shaped sarcomas, its diagnosis is always one of exclusion. The likelihood of misdiagnoses between similar tumour entities is high, and often leads to inappropriate tumour treatment. We summarize here the main features of fibrosarcoma. When fibrosarcoma is appropria...

2017
Carola Murphy Elizabeth Rettedal Panos Lehouritis Ciarán Devoy Mark Tangney

Systemic administration of the highly potent anticancer therapeutic, tumour necrosis factor alpha (TNFα) induces high levels of toxicity and is responsible for serious side effects. Consequently, tumour targeting is required in order to confine this toxicity within the locality of the tumour. Bacteria have a natural capacity to grow within tumours and deliver therapeutic molecules in a controll...

2014
Anna-Karin Haylock Diana Spiegelberg Johan Nilvebrant Karl Sandström Marika Nestor

BACKGROUND Patients with squamous cell carcinoma in the head and neck region (HNSCC) offer a diagnostic challenge due to difficulties to detect small tumours and metastases. Imaging methods available are not sufficient, and radio-immunodiagnostics could increase specificity and sensitivity of diagnostics. The objective of this study was to evaluate, for the first time, the in vivo properties of...

2014
Vasso Apostolopoulos Geoffrey A Pietersz Anastasios Tsibanis Annivas Tsikkinis Lily Stojanovska Ian FC McKenzie Stamatis Vassilaros

The use of tumour-associated antigens for cancer immunotherapy studies is exacerbated by tolerance to these self-antigens. Tolerance may be broken by using ex vivo monocyte-derived dendritic cells (DCs) pulsed with self-antigens. Targeting tumour-associated antigens directly to DCs in vivo is an alternative and simpler strategy. The identification of cell surface receptors on DCs, and targeting...

2011
Matthew Morrison Alan Cuthbertson

Despite the recent development of various radiolabelled RGD peptides for imaging the αvβ3 integrin receptor, relatively little attention has been focused on the ability of these radiotracers to monitor changes in tumour vascularity following treatment with anti-tumour therapies. Here we describe the favourable in vivo kinetics and tumour targeting properties of several novel radiolabeled RGD co...

Journal: :Nature nanotechnology 2011
Georgy Mikhaylov Ursa Mikac Anna A Magaeva Volya I Itin Evgeniy P Naiden Ivan Psakhye Liane Babes Thomas Reinheckel Christoph Peters Robert Zeiser Matthew Bogyo Vito Turk Sergey G Psakhye Boris Turk Olga Vasiljeva

The tumour microenvironment regulates tumour progression and the spread of cancer in the body. Targeting the stromal cells that surround cancer cells could, therefore, improve the effectiveness of existing cancer treatments. Here, we show that magnetic nanoparticle clusters encapsulated inside a liposome can, under the influence of an external magnet, target both the tumour and its microenviron...

2013
Jennifer H. E. Baker Alastair H. Kyle Kirsten L. Bartels Stephen P. Methot Erin J. Flanagan Andrew Balbirnie Jordan D. Cran Andrew I. Minchinton

Many cancer research efforts focus on exploiting genetic-level features that may be targeted for therapy. Tissue-level features of the tumour microenvironment also represent useful therapeutic targets. Here we investigate the presence of low oxygen tension and sensitivity to NOS inhibition of tumour vasculature as potential tumour-specific features that may be targeted by hypoxic cytotoxins, a ...

2014
Ahmed El Kaffas Joris Nofiele Anoja Giles Song Cho Stanley K. Liu Gregory J. Czarnota

Tumour vasculature acts as an essential lifeline for tumour progression and facilitates metastatic spread. Novel vascular targeting strategies aiming to sustain vascular shutdown could potentially induce substantial damage, resulting in a significant tumour growth delay. We investigated the combination of two novel complementary vascular targeting agents with radiation therapy in a strategy aim...

2013
Sahar A Saddoughi Salih Gencer Yuri K Peterson Katherine E Ward Archana Mukhopadhyay Joshua Oaks Jacek Bielawski Zdzislaw M Szulc Raquela J Thomas Shanmugam P Selvam Can E Senkal Elizabeth Garrett-Mayer Ryan M De Palma Dzmitry Fedarovich Angen Liu Amyn A Habib Robert V Stahelin Danilo Perrotti Besim Ogretmen

Mechanisms that alter protein phosphatase 2A (PP2A)-dependent lung tumour suppression via the I2PP2A/SET oncoprotein are unknown. We show here that the tumour suppressor ceramide binds I2PP2A/SET selectively in the nucleus and including its K209 and Y122 residues as determined by molecular modelling/simulations and site-directed mutagenesis. Because I2PP2A/SET was found overexpressed, whereas c...

Journal: :Oncology reports 2014
Bo Gao Yingmei Wang Yan Qiu Weiliang Xia Xianzhi Meng Ming Lu Weihui Zhang Xin Qiao Yingmei Zhang Dongbo Xue

As an important component of tumour stroma, tumour-associated macrophages (TAMs) promote tumour development and progression. Herbs have been increasingly used in anticancer therapies due to their wide-ranging anticancer effects and minor side-effects. However, no herb-based treatments targeting TAMs have yet been proposed. To address this issue, screening using modular analysis bioinformatics t...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید